Patient Referral and Acceptance of Maxillomandibular Advancement for Obstructive Sleep Apnea
The Laryngoscope · 2024
DOI: 10.1002/lary.31152 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Julianna Rodin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania, U.S.A. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Mandibular Advancement, Referral and Consultation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Objective
Maxillomandibular advancement (MMA) is an effective surgical treatment for obstructive sleep apnea (OSA); however, it is unclear how many patients who are referred for MMA actually undergo surgery. This study aims to determine follow‐up rates for patients referred for MMA and the reasons behind their choices.
Methods
Via retrospective review, we assessed consecutive patients with OSA intolerant to continuous positive airway pressure (CPAP) who underwent drug induced sleep endoscopy (DISE) between 2018 and 2020 at our institution. Patients recommended for MMA based on DISE and other findings were included. Patients were then contacted and administered an IRB‐approved survey in present time.
Results
One hundred and fifty nine patients were referred to oral maxillofacial surgery (OMFS) for MMA consult. Seventy seven patients (48%) followed up with OMFS and 29 (18%) underwent MMA. Sixty two (40%) patients resumed CPAP. Fifty eight patients (36.5%) were lost to follow up. Seventy three patients (46%) completed our survey. Of those patients, 37 (51%) followed up with OMFS and 17 (23%) underwent MMA. Patients who did not follow up with OMFS cited the invasiveness of the surgery (39%), recovery time (17%), or both (31%) as reasons. Those who pursued consultation cited inability to tolerate CPAP (73%), not being a candidate for inspire (14%), and desire to learn about alternative treatments (14%) as reasons. Of those who did not undergo MMA, 28.6% are not using OSA treatment.
Conclusion
Less than half of patients referred for MMA followed up, and less than half of those patients underwent MMA. Most patients cited concerns about the invasiveness of the surgery and recovery process. Level of Evidence 4 Laryngoscope , 134:2964–2969, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania, U.S.A.
- Department of Oral and Maxillofacial Surgery, Thomas Jefferson University Hospitals, Philadelphia, Pennsylvania, U.S.A.
ORCID-Profile: Julianna Rodin, Michele Fiorella, Colin Huntley
Zitieren
APA
Rodin, J., Fiorella, M., Crippen, M., Best, K., Taub, D., Champion, A., Boon, M., & Huntley, C. (2024). Patient Referral and Acceptance of Maxillomandibular Advancement for Obstructive Sleep Apnea. The Laryngoscope. https://doi.org/10.1002/lary.31152
Vancouver
Rodin J, Fiorella M, Crippen M, Best K, Taub D, Champion A, et al. Patient Referral and Acceptance of Maxillomandibular Advancement for Obstructive Sleep Apnea. The Laryngoscope. 2024. doi:10.1002/lary.31152
BibTeX
@article{Rodin2024,
author = {Rodin, Julianna and Fiorella, Michele and Crippen, Meghan and Best, Keisha and Taub, Daniel and Champion, Allen and Boon, Maurits and Huntley, Colin},
title = {Patient Referral and Acceptance of Maxillomandibular Advancement for Obstructive Sleep Apnea},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31152}
}
EUVIMED